Literature DB >> 23105295

Enhanced expression of HMG-Y proteins in proliferating tissues.

D Singh1, M R Rajeswari.   

Abstract

The high mobility group (HMG) proteins I and Y are well characterised non-histone chromosomal proteins which bind to A-T rich regions of DNA and regulate gene expression and/or DNA replication. A correlation has been demonstrated between the increased expression of HMG-Y proteins and malignancy. However, it is not known whether the expression of HMGs particularly, the Y group, is a function of proliferation rate. In the present study, we have used normal tissues of calf testes, thymus and liver. The results show distinctly high expression of HMG-Y proteins in testes than in thymus and the expression was practically undetectable in liver. The results suggest that even in normal tissues there is a direct correlation between the proliferation rate and the expression of the HMG-Y proteins, which can partly explain its increased expression in cancer.

Entities:  

Keywords:  Cancer; Cell Proliferation; HMG-Y proteins

Year:  2001        PMID: 23105295      PMCID: PMC3453602          DOI: 10.1007/BF02867571

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  Purification and assays for high mobility group HMG-I(Y) protein function.

Authors:  R Reeves; M S Nissen
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  An improved large scale fractionation of high mobility group non-histone chromatin proteins.

Authors:  G H Goodwin; R H Nicolas; E W Johns
Journal:  Biochim Biophys Acta       Date:  1975-10-20

Review 3.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

Authors:  M Bustin; R Reeves
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1996

4.  HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes.

Authors:  G Tallini; R Vanni; G Manfioletti; B Kazmierczak; G Faa; P Pauwels; J Bullerdiek; V Giancotti; H Van Den Berghe; P Dal Cin
Journal:  Lab Invest       Date:  2000-03       Impact factor: 5.662

5.  Partial fractionation and chemical characterization of the major nonhistone chromosomal proteins.

Authors:  S C Elgin; J Bonner
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

6.  HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.

Authors:  W M Liu; F K Guerra-Vladusic; S Kurakata; R Lupu; T Kohwi-Shigematsu
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

7.  Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.

Authors:  G Tallini; P Dal Cin; K J Rhoden; G Chiapetta; G Manfioletti; V Giancotti; A Fusco; H Van den Berghe; R Sciot
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures.

Authors:  V Giancotti; E Buratti; L Perissin; S Zorzet; A Balmain; G Portella; A Fusco; G H Goodwin
Journal:  Exp Cell Res       Date:  1989-10       Impact factor: 3.905

9.  High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse.

Authors:  V Giancotti; A Bandiera; L Ciani; D Santoro; C Crane-Robinson; G H Goodwin; M Boiocchi; R Dolcetti; B Casetta
Journal:  Eur J Biochem       Date:  1993-04-15

10.  Microheterogeneity of the mammalian high mobility group (HMG) proteins 1 and 2 investigated by reverse-phase high performance liquid chromatography.

Authors:  T S Elton; R Reeves
Journal:  Anal Biochem       Date:  1985-02-01       Impact factor: 3.365

View more
  1 in total

1.  p53 CRISPR Deletion Affects DNA Structure and Nuclear Architecture.

Authors:  Aline Rangel-Pozzo; Samuel Booth; Pak Lok Ivan Yu; Madhurendra Singh; Galina Selivanova; Sabine Mai
Journal:  J Clin Med       Date:  2020-02-22       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.